Company Overview of KeraCure, Inc.
KeraCure, Inc. develops and commercializes therapies and technologies for tissue regeneration. The company’s wound healing technology is designed to improve the natural regenerative process of the human body. It offers KeraPac, a living tissue that stimulates the body’s own natural healing process by activating its ability to repair and regenerate tissue. The company covers chronic wounds for additional regenerative medicine applications, including bone restoration and nerve regeneration under clinical product pipeline. Its products are also used as a therapy for diabetic foot ulcers and other chronic wounds. KeraCure, Inc. was founded in 1999 and is based in Chicago, Illinois.
101 North Wacker Drive
Chicago, IL 60606
Founded in 1999
Key Executives for KeraCure, Inc.
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3Bar Biologics Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact KeraCure, Inc., please visit www.keracure.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.